Skip to content

Factors affecting ultrasonography during second trimester fetal anatomic scan

Factors affecting ultrasonography during second trimester fetal anatomic scan

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12618000759291
Enrollment
240
Registered
2018-05-07
Start date
2018-06-01
Completion date
2018-07-31
Last updated
2018-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Ultrasonography (USG) has become an important part of antenatal care. It is used for various reasons during pregnancy such as locating the pregnancy, viability, fetal biometry and fetal anatomic evaluation. As technology advances, both patients and physicians are expecting to diagnose more medical conditions in utero. However several factors are still need to be overcome in order to visualize properly during the USG examinations. Both maternal and fetal factors affect the quality of imaging. These include maternal obesity, previous abdominal/pelvic surgeries, subcutaneous injections, multiple pregnancies etc. As there is more negative factors for imaging quality, the quality of imaging decreases; which in turn makes the examination times longer and accuracy of diagnoses lesser. These may also cause some medicolegal problems for the physicians. Furthermore, standardization of reporting imaging quality will be beneficial for USG studies for describing the patient characteristics more clearly. Therefore, there is a need for standardization of imaging quality during reporting. In this study it is aimed to evaluate the effects of various factors in order to standardize the reporting of imaging quality during second trimester fetal anatomic scan. Materials and Methods In this prospective cohort study, patients who were admitted for routine second trimester fetal anatomic evaluation with USG between May 2018 and June 2018 were included. Patients between 19-23 weeks of gestation were included. All dating were confirmed with the first trimester CRL measurements. Patients with fetal anatomic/chromosomal anomalies were excluded from the study. All examinations were done by the same physician using Voluson E6 (GE) with the abdominal curved probe RAB6-D. The examination was done as the standards set by ISUOG. As there was no intervention, ethical committee approval was not required, however all patients gave informed consent that their data for use for scientific purposes. Skin to uterus distance was measured in the midpoint between symphysis- umbilicus distance.

Interventions

All examinations were done by the same physician using Voluson E6 (GE) with the abdominal curved probe RAB6-D. The examination was done as the standards set by ISUOG. Skin to uterus distance was measured in the midpoint between symphysis- umbilicus distance. Measuring the distance between maternal skin and uterus by ultrasonography. Single examination of approximately 10-30 minutes duration.

Sponsors

Cihan Cetin
Lead SponsorIndividual

Eligibility

Sex/Gender
All
Age
15 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

19-23 weeks pregnancy. Normal fetal anatomy

Exclusion criteria

Fetal anomaly(structural/chromosomal) Patients with unknown first trimester CRL measurement

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026